Insider Trends: 90-Day Insider Buying Trend Reduced with Disposition of CVS Health Shares
05:20 PM EDT, 05/10/2021 (MT Newswires) -- On May 07, 2021, EVP and Chief Medical Officer, Dr Troyen A Brennan, executed a sale of 9,477 shares in CVS Health (CVS) for $796,068. After the Form 4 filing with the SEC, Dr Brennan owns 144,697 shares of company stock, which have a market value of $12.3 million as of the prior-day closing price.
In the 90 days previous to the date of this filing, there have been 20 insider transactions reported to the SEC for CVS Health. These transactions came from the activities of 8 individual insiders that resulted in a net acquisition of 33,587 company shares. This compares with the preceding 90-day window of time where there were 40 transactions from 19 insiders that resulted in the net acquisition of 527,103 shares.
This level of insider transactions is below that of the peer group average in the 54-company Healthcare Facilities & Services peer group over the last 90-day period. Peer group activity averaged 110.6 transactions per company, and disposition of 3,662 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/64803/000112760221016099/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.